17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Hydroxyprogesterone caproate.
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Miglitol.
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Miglitol.
Advertisement
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Miglitol.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Miglitol.
Anhydrous Tacrolimus
The therapeutic efficacy of Miglitol can be decreased when used in combination with Tacrolimus.
Advertisement
Aripiprazole
The therapeutic efficacy of Miglitol can be decreased when used in combination with Aripiprazole.
Arsenic Trioxide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Articaine.
Advertisement
Asenapine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Miglitol.
Atazanavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Atazanavir.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Miglitol.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Miglitol.
Bendroflumethiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Bendroflumethiazide.
Benzthiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Benzthiazide.
Betamethasone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Betamethasone.
Brexpiprazole
The therapeutic efficacy of Miglitol can be decreased when used in combination with Brexpiprazole.
Bumetanide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Bumetanide.
Buserelin
The therapeutic efficacy of Miglitol can be decreased when used in combination with Buserelin.
Ceritinib
The therapeutic efficacy of Miglitol can be decreased when used in combination with Ceritinib.
Chlorothiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Miglitol may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Chlorthalidone.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Miglitol.
Ciprofloxacin
Ciprofloxacin may increase the hypoglycemic activities of Miglitol.
Citalopram
Citalopram may increase the hypoglycemic activities of Miglitol.
Clozapine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Miglitol can be increased when used in combination with Ubidecarenone.
Corticotropin
The therapeutic efficacy of Miglitol can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Cortisone acetate.
Cyclopenthiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Cyclopenthiazide.
Cyproterone Acetate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The therapeutic efficacy of Miglitol can be decreased when used in combination with Dabrafenib.
Danazol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Danazol.
Darunavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Darunavir.
Desogestrel
The therapeutic efficacy of Miglitol can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Miglitol.
Dexamethasone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Diazoxide.
Dienogest
The therapeutic efficacy of Miglitol can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Miglitol.
Disopyramide
Miglitol may increase the hypoglycemic activities of Disopyramide.
Drospirenone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Drospirenone.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Miglitol.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Miglitol.
Epinephrine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Epinephrine.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Miglitol.
Estradiol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Miglitol can be decreased when used in combination with Etacrynic acid.
Ethinyl Estradiol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Ethynodiol diacetate.
Etonogestrel
The therapeutic efficacy of Miglitol can be decreased when used in combination with Etonogestrel.
Everolimus
The therapeutic efficacy of Miglitol can be decreased when used in combination with Everolimus.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Miglitol.
Fludrocortisone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Fludrocortisone.
Flumequine
Flumequine may increase the hypoglycemic activities of Miglitol.
Fluoxetine
Fluoxetine may increase the hypoglycemic activities of Miglitol.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Miglitol.
Fluvoxamine
Fluvoxamine may increase the hypoglycemic activities of Miglitol.
Fosamprenavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Fosamprenavir.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Miglitol.
Furosemide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Furosemide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Miglitol.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Miglitol.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Miglitol.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Miglitol.
Gliclazide
Miglitol may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Miglitol may increase the hypoglycemic activities of Glimepiride.
Glipizide
Miglitol may increase the hypoglycemic activities of Glipizide.
Glyburide
Miglitol may increase the hypoglycemic activities of Glyburide.
Goserelin
The therapeutic efficacy of Miglitol can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Miglitol.
Histrelin
The therapeutic efficacy of Miglitol can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Miglitol can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Indapamide.
Indinavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Indinavir.
INDINAVIR ANHYDROUS
The therapeutic efficacy of Miglitol can be decreased when used in combination with Indinavir.
Insulin Detemir
Miglitol may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Miglitol may increase the hypoglycemic activities of Insulin Glargine.
insulin human, rDNA origin
Miglitol may increase the hypoglycemic activities of Insulin Human.
Insulin Lispro
Miglitol may increase the hypoglycemic activities of Insulin Lispro.
Insulin, Aspart Protamine, Human
Miglitol may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Miglitol may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Miglitol may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Protamine Lispro, Human
Miglitol may increase the hypoglycemic activities of Insulin Lispro.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Miglitol.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Miglitol.
Lanreotide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Lanreotide.
Leuprolide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Leuprolide.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Miglitol.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Miglitol.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Miglitol.
Levonorgestrel
The therapeutic efficacy of Miglitol can be decreased when used in combination with Levonorgestrel.
Lomefloxacin
Lomefloxacin may increase the hypoglycemic activities of Miglitol.
Lopinavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Lopinavir.
Lurasidone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Lurasidone.
Mecasermin
Miglitol may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Miglitol may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Miglitol can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Megestrol acetate.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Miglitol.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Miglitol.
Mestranol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Mestranol.
Methotrimeprazine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Miglitol.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Miglitol.
Methylprednisolone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Miglitol.
Metolazone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Metolazone.
Mifepristone
Miglitol may increase the hypoglycemic activities of Mifepristone.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Miglitol.
Minaprine
Minaprine may increase the hypoglycemic activities of Miglitol.
Moclobemide
Moclobemide may increase the hypoglycemic activities of Miglitol.
Moxifloxacin
Moxifloxacin may increase the hypoglycemic activities of Miglitol.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Miglitol.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Miglitol.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Miglitol.
Nateglinide
Miglitol may increase the hypoglycemic activities of Nateglinide.
Nefazodone
Nefazodone may increase the hypoglycemic activities of Miglitol.
Nelfinavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Nelfinavir.
Niacin
The therapeutic efficacy of Miglitol can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Miglitol.
Nilotinib
The therapeutic efficacy of Miglitol can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Miglitol.
Norgestimate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Norgestimate.
Octreotide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Octreotide.
Ofloxacin
Ofloxacin may increase the hypoglycemic activities of Miglitol.
Olanzapine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Miglitol.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Miglitol.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Miglitol.
Paliperidone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Paliperidone.
Pargyline
Pargyline may increase the hypoglycemic activities of Miglitol.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Miglitol.
Pasireotide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Pasireotide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Miglitol.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Miglitol.
Pentamidine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Pentamidine.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Miglitol.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Miglitol.
Piperazine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Polythiazide.
Prednisolone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Miglitol.
Procaine
Procaine may increase the hypoglycemic activities of Miglitol.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Miglitol.
Progesterone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Progesterone.
Quetiapine
The therapeutic efficacy of Miglitol can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Quinethazone.
Quinine
Miglitol may increase the hypoglycemic activities of Quinine.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Miglitol.
Regular Insulin, Human
Miglitol may increase the hypoglycemic activities of Insulin Human.
Repaglinide
Miglitol may increase the hypoglycemic activities of Repaglinide.
Risperidone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Ritonavir.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Miglitol.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Miglitol.
Saquinavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Miglitol can be decreased when used in combination with Saquinavir.
Selegiline
Selegiline may increase the hypoglycemic activities of Miglitol.
Sertraline
Sertraline may increase the hypoglycemic activities of Miglitol.
Sirolimus
The therapeutic efficacy of Miglitol can be decreased when used in combination with Sirolimus.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Miglitol.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Miglitol.
Sulfadiazine
Miglitol may increase the hypoglycemic activities of Sulfadiazine.
Sulfamethoxazole
Miglitol may increase the hypoglycemic activities of Sulfamethoxazole.
Sulfisoxazole
Miglitol may increase the hypoglycemic activities of Sulfisoxazole.
Sunitinib
Miglitol may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
The therapeutic efficacy of Miglitol can be decreased when used in combination with Tacrolimus.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Miglitol.
Temsirolimus
The therapeutic efficacy of Miglitol can be decreased when used in combination with Temsirolimus.
Testosterone
Testosterone may increase the hypoglycemic activities of Miglitol.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Miglitol.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Miglitol.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Miglitol.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Miglitol.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Miglitol.
Tipranavir
The therapeutic efficacy of Miglitol can be decreased when used in combination with Tipranavir.
Tolazamide
Miglitol may increase the hypoglycemic activities of Tolazamide.
Tolbutamide
Miglitol may increase the hypoglycemic activities of Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Miglitol.
Torsemide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Torasemide.
Tranylcypromine
Tranylcypromine may increase the hypoglycemic activities of Miglitol.
Triamcinolone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Miglitol can be decreased when used in combination with Trichlormethiazide.
Triptorelin
The therapeutic efficacy of Miglitol can be decreased when used in combination with Triptorelin.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Miglitol.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Miglitol.
Venlafaxine
Venlafaxine may increase the hypoglycemic activities of Miglitol.
Vorinostat
The therapeutic efficacy of Miglitol can be decreased when used in combination with Vorinostat.
Ziprasidone
The therapeutic efficacy of Miglitol can be decreased when used in combination with Ziprasidone.
